Decreased expression of Nedd4L correlates with poor prognosis in gastric cancer patient

Medical Oncology

Volumn 29, Issue 3, 2012, Pages 1733-1738

  Gao, Chengcheng ^a   Pang, Liqun ^a   Ren, Chengcheng ^a   Ma, Tianheng ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Developmentally down regulated 4 like; Expression; Gastric cancer; Immunohistochemistry; Neural precursor cell expressed; Prognosis

Indexed keywords

NEDD4L PROTEIN; UBIQUITIN PROTEIN LIGASE NEDD4; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UBIQUITIN-PROTEIN LIGASES; YOUNG ADULT;

EID: 84869867065     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-0061-3     Document Type: Article

References (13)

1. Atmaca A, Pauligk C, Steinmetz K, et al. Prognostic impact of phosphorylated mitogen-activated protein kinase expression in patients with metastatic gastric cancer. Oncology. 2011;80: 130-4.
2. Ye YW, Dong RZ, Zhou Y, et al. Prognostic analysis of familial gastric cancer in Chinese population. J Surg Oncol. 2011;104: 76-82.
3. Zhang YZ, Zhang LH, Gao Y, et al. Discovery and validation of prognostic markers in gastric cancer by genome-wide expression profiling. World J Gastroenterol. 2011;17:1710-7.
4. Chen H, Ross CA, Wang N, et al. NEDD4L on human chromosome 18q21 has multiple forms of transcripts and is a homologue of the mouse Nedd4-2 gene. Eur J Hum Genet. 2001; 9:922-30.
5. Dunn DM, Ishigami T, Pankow J, et al. Common variant of human NEDD4L activates a cryptic splice site to form a frameshifted transcript. J Hum Genet. 2002;47:665-76.
6. Flasza M, Gorman P, Roylance R, et al. Alternative splicing determines the domain structure of WWP1, a Nedd4 family protein. Biochem Biophys Res Commun. 2002;290:431-7.
7. Takeuchi T, Adachi Y, Nagayama T, et al. Nedd4L modulates the transcription of metalloproteinase-1 and -13 genes to increase the invasive activity of gallbladder cancer. Int J Exp Pathol. 2011;92:79-86.
8. Hu XY, Xu YM, Fu Q, et al. Nedd4L expression is downregulated in prostate cancer compared to benign prostatic hyperplasia. Eur J Surg Oncol. 2009;35:527-31.
9. Sobin LH, Wittekind C. TNM classification of malignant tumours. 6th ed. New York: Wiley, International Union Against Cancer; 2002.
10. Lee HS, Park MH, Yang SJ, et al. Novel candidate targets of Wnt/beta-catenin signaling in hepatoma cells. Life Sci. 2007;80: 690-8.
11. Wyatt L, Wadham C, Crocker LA, et al. The protein tyrosine phosphatase Pez regulates TGFbeta, epithelial-mesenchymal transition, and organ development. J Cell Biol. 2007;178: 1223-35.
12. Qi H, Grenier J, Fournier A, et al. Androgens differentially regulate the expression of NEDD4L transcripts in LNCaP human prostate cancer cells. Mol Cell Endocrinol. 2003;210:51-62.
13. Hellwinkel OJ, Asong LE, Rogmann JP, et al. Transcription alterations of members of the ubiquitin-proteasome network in prostate carcinoma. Prostate Cancer Prostatic Dis. 2011;14: 38-45.